• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Spotlight on Glycan Pairing: The Generation and Impact of Monoclonal Antibody Asymmetrical Fc N‑Glycan Pairs on Fc Receptor Interaction.聚糖配对聚焦:单克隆抗体不对称Fc N-聚糖配对对Fc受体相互作用的产生及影响
ACS Pharmacol Transl Sci. 2025 May 21;8(6):1756-1767. doi: 10.1021/acsptsci.5c00185. eCollection 2025 Jun 13.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing.解析甘露糖受体与单抗的相互作用:高甘露糖 N-聚糖和聚糖配对的重要性。
MAbs. 2024 Jan-Dec;16(1):2400414. doi: 10.1080/19420862.2024.2400414. Epub 2024 Sep 8.
2
Enhanced N-Glycan Profiling of Therapeutic Monoclonal Antibodies through the Application of Upper-Hinge Middle-Up Level LC-HRMS Analysis.通过应用上铰链区中上游水平液相色谱-高分辨质谱分析增强治疗性单克隆抗体的N-聚糖谱分析
Antibodies (Basel). 2024 Aug 6;13(3):66. doi: 10.3390/antib13030066.
3
Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation.系统制备具有对称和非对称均一聚糖的 66- IgG 文库及其功能评价。
J Am Chem Soc. 2024 Aug 21;146(33):23426-23436. doi: 10.1021/jacs.4c06558. Epub 2024 Aug 6.
4
Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact.治疗性抗体和含 Fc 的生物疗法中聚糖配对的综合分析和表征:解决当前的局限性及其对 N-糖基化影响的意义。
Eur J Pharm Biopharm. 2024 Jul;200:114325. doi: 10.1016/j.ejpb.2024.114325. Epub 2024 May 15.
5
A low-temperature SPR-based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B.基于低温 SPR 的分析方法,用于使用 FcγRIIA/B 评估单克隆抗体的半乳糖基化和岩藻糖化。
Biotechnol Bioeng. 2024 May;121(5):1659-1673. doi: 10.1002/bit.28673. Epub 2024 Feb 14.
6
Antibodies to watch in 2024.2024 年值得关注的抗体药物
MAbs. 2024 Jan-Dec;16(1):2297450. doi: 10.1080/19420862.2023.2297450. Epub 2024 Jan 5.
7
Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems.哺乳动物细胞表达系统生产的治疗性单克隆抗体的基准聚糖谱
Pharm Res. 2024 Jan;41(1):29-37. doi: 10.1007/s11095-023-03628-4. Epub 2023 Nov 1.
8
Therapeutic Antibodies in Medicine.医学中的治疗性抗体。
Molecules. 2023 Sep 5;28(18):6438. doi: 10.3390/molecules28186438.
9
Chromatographic Analysis of the -Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography.使用FcγRIIIa亲和柱色谱法对治疗性抗体上的-Glycan谱进行色谱分析。
ACS Omega. 2023 Apr 28;8(18):16513-16518. doi: 10.1021/acsomega.3c02374. eCollection 2023 May 9.
10
Development of therapeutic antibodies for the treatment of diseases.用于疾病治疗的治疗性抗体的研发。
Mol Biomed. 2022 Nov 22;3(1):35. doi: 10.1186/s43556-022-00100-4.

聚糖配对聚焦:单克隆抗体不对称Fc N-聚糖配对对Fc受体相互作用的产生及影响

Spotlight on Glycan Pairing: The Generation and Impact of Monoclonal Antibody Asymmetrical Fc N‑Glycan Pairs on Fc Receptor Interaction.

作者信息

Meudt Maximilian, Baumeister Julia, Machal Erik M F, Knape Matthias J, Mizaikoff Boris, Ebert Sybille, Rosenau Frank, Blech Michaela, Higel Fabian

机构信息

Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss 88400, Germany.

Institute of Analytical and Bioanalytical Chemistry, Ulm University, Ulm 89069, Germany.

出版信息

ACS Pharmacol Transl Sci. 2025 May 21;8(6):1756-1767. doi: 10.1021/acsptsci.5c00185. eCollection 2025 Jun 13.

DOI:10.1021/acsptsci.5c00185
PMID:40534672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12171887/
Abstract

Monoclonal antibodies' Fc N-glycans play a crucial role in their therapeutic efficacy, as they influence effector functions through Fc receptor binding. However, the impact of asymmetrical Fc glyco-pairs is often overlooked in assessing Fc receptor binding and effector functions. This study addresses this gap by generating pure asymmetrical Fc glyco-pairs and evaluating their Fc receptor binding properties, thereby providing a comprehensive understanding of the impact of Fc N-glycans. Utilizing redox pairing and affinity chromatography, homogeneously asymmetrical Fc glyco-pairs were generated, and their interaction properties toward Fcγ receptors IIIa, IIa, IIb, and I were determined by surface plasmon resonance. The results underscore the importance of considering the apparent glycan distribution of Fc N-glycans as glycan pairing was found to individually influence Fc receptor binding. Notably, single afucosylation significantly increased the affinity for FcγRIIIa, while the effect of galactosylation was detectable but less pronounced. Galactosylation, however, played a crucial role in FcγRIIa binding, with asymmetrical galactosylation being sufficient for the whole effect. In contrast, for FcγRIIb, afucosylation was more important, while galactosylation played a minor role. Furthermore, glycosylation-dependent Fc-FcγRI complex stability differences could be resolved, challenging the commonly held belief that this interaction is glycosylation independent.

摘要

单克隆抗体的Fc N-聚糖在其治疗效果中起着关键作用,因为它们通过Fc受体结合影响效应功能。然而,在评估Fc受体结合和效应功能时,不对称Fc糖对的影响常常被忽视。本研究通过生成纯的不对称Fc糖对并评估其Fc受体结合特性来填补这一空白,从而全面了解Fc N-聚糖的影响。利用氧化还原配对和亲和色谱法,生成了均匀的不对称Fc糖对,并通过表面等离子体共振测定了它们与Fcγ受体IIIa、IIa、IIb和I的相互作用特性。结果强调了考虑Fc N-聚糖的表观聚糖分布的重要性,因为发现聚糖配对会单独影响Fc受体结合。值得注意的是,单去岩藻糖基化显著增加了对FcγRIIIa的亲和力,而半乳糖基化的影响虽然可检测到但不太明显。然而,半乳糖基化在FcγRIIa结合中起关键作用,不对称半乳糖基化足以产生整体效应。相比之下,对于FcγRIIb,去岩藻糖基化更重要,而半乳糖基化起次要作用。此外,糖基化依赖性的Fc-FcγRI复合物稳定性差异可以得到解决,这挑战了普遍认为这种相互作用与糖基化无关的观点。